Experimental transplant aims to tame aggressive blood cancer
NCT ID NCT03441958
Summary
This study tested a new type of stem cell transplant for people with high-risk multiple myeloma, a serious blood cancer. Doctors used specially treated umbilical cord blood cells for the transplant, hoping it would be safer and more effective than standard transplants. The main goals were to see if the procedure was safe and if it could help control the cancer long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond
Montreal, Quebec, H1T2M4, Canada
Conditions
Explore the condition pages connected to this study.